Not applicableNot Yet RecruitingNCT07724652What this trial is testingThe AYA Oncology Self-care MovementWho this might be right forAcute Lymphobkastic LeukemiaMedication Adherence Northwestern University 200
Early research (Phase 1)Active Not RecruitingNCT02050347What this trial is testingActivated T Lymphocytes Expressing CARs, Relapsed CD19+ Malignancies Post-Allo HSCT(CARPASCIO)Who this might be right forNon-Hodgkin's LymphomaB-Cell ALLB-Cell CLL Baylor College of Medicine 7
Early research (Phase 1)Study completedNCT01328626What this trial is testingStudy Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin LymphomaWho this might be right forChronic Lymphocytic LeukemiaNon-Hodgkin Lymphoma AbbVie 222
Not applicableStudy completedNCT03234335What this trial is testingHigh Dose Therapy Followed by Autologous Transplantation for Myeloma Patients With Severe Renal ImpairmentWho this might be right forMultiple MyelomaRenal Failure Centre Hospitalier Universitaire de Saint Etienne 50
Early research (Phase 1)Study completedNCT00889408What this trial is testingDT2219ARL for Relapsed or Refractory CD19 (+), CD 22 (+) B-Lineage Leukemia Or LymphomaWho this might be right forLeukemiaLymphoma Masonic Cancer Center, University of Minnesota 25
Testing effectiveness (Phase 2)Study completedNCT00014508What this trial is testingChemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple MyelomaWho this might be right forMultiple Myeloma and Plasma Cell Neoplasm Eastern Cooperative Oncology Group
Not applicableStudy completedNCT06168825What this trial is testingMind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive InterventionWho this might be right forCancerBreast CancerBrain Cancer+13 more Inova Health Care Services 40
Early research (Phase 1)Looking for participantsNCT07249840What this trial is testingRopeginterferon for High Risk JAK2 Clonal HematopoiesisWho this might be right forJAK2 Mutation Brigham and Women's Hospital 12
Testing effectiveness (Phase 2)Study completedNCT00475150What this trial is testingCediranib Maleate in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+8 more National Cancer Institute (NCI) 39
Not applicableLooking for participantsNCT06956755What this trial is testingRegistry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid LeukemiaWho this might be right forMyelodysplastic SyndromesLeukemia, Myeloid, Acute Groupe Francophone des Myelodysplasies 6,990
Testing effectiveness (Phase 2)Looking for participantsNCT00501826What this trial is testingCombination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaWho this might be right forT Acute Lymphoblastic LeukemiaT Lymphoblastic Lymphoma M.D. Anderson Cancer Center 160
Early research (Phase 1)UnknownNCT04727008What this trial is testingCXCR4 Modified Anti-BCMA CAR T Cells for Multiple MyelomaWho this might be right forMultiple Myeloma Sichuan University 12
Testing effectiveness (Phase 2)Ended earlyNCT00262925What this trial is testingCombination Chemotherapy and Alemtuzumab in Treating Patients With Relapsed or Refractory Acute Lymphoblastic LeukemiaWho this might be right forRecurrent Adult Acute Lymphoblastic Leukemia National Cancer Institute (NCI) 12
Not applicableLooking for participantsNCT07285668What this trial is testingProphylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic MalignanciesWho this might be right forHematologic Malignancies University of Wisconsin, Madison 38
Testing effectiveness (Phase 2)Study completedNCT02169791What this trial is testingNonmyeloablative Haploidentical Transplant Followed by MLN9708Who this might be right forAcute LeukemiaChronic LeukemiaMyelodysplastic Syndrome+2 more Northside Hospital, Inc. 29
Large-scale testing (Phase 3)Looking for participantsNCT05586074What this trial is testingHEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AMLWho this might be right forLeukemia, Acute Myeloid (AML) Sunshine Lake Pharma Co., Ltd. 324
Not applicableStudy completedNCT05687474What this trial is testingBaby Detect : Genomic Newborn ScreeningWho this might be right forCongenital Adrenal HyperplasiaFamilial Hyperinsulinemic Hypoglycemia 1Phosphoglucomutase 1 Deficiency+121 more Centre Hospitalier Universitaire de Liege 6,824
Testing effectiveness (Phase 2)Study completedNCT02891811What this trial is testingPatients With Newly Diagnosed Multiple Myeloma Comparing KTd vs. KRd Induction Therapy and Investigating a K-mono Maintenance StrategyWho this might be right forMultiple Myeloma Arbeitsgemeinschaft medikamentoese Tumortherapie 124
Not applicableNot Yet RecruitingNCT07703644What this trial is testingCeftazidime-Avibactam PK/PD and Resistance in Hematology PatientsWho this might be right forHematologic NeoplasmsGram-Negative Bacterial InfectionsPseudomonas Aeruginosa Infection+2 more Sizhou Feng 60
Early research (Phase 1)Study completedNCT01397799What this trial is testingEvaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML)Who this might be right forAcute Myelogenous Leukemia Kinex Pharmaceuticals Inc. 24